Genome-wide association study

A study that scans the DNA of thousands of people with and without a condition to find gene regions linked to it.

Also called: gwas, genetic study, genetics, susceptibility gene, risk genes

Related words nod2

Topics Research

Questions people ask

Is Crohn's disease genetic?

Partly. In 2001 researchers found the first gene firmly linked to Crohn's, NOD2, which helps the immune system recognise bacteria. Later large studies found many more gene regions, each adding a small amount of risk, and many are shared with other immune conditions. Having these gene changes does not mean you will get Crohn's; gut bacteria and environment also play a part.

Sources

How can I take part in a Crohn's clinical trial?

The NHS suggests asking your doctor or a patient organisation about trials you may be eligible for. You can also search the NIHR's Be Part of Research website for UK studies and contact research teams directly. Registries such as ISRCTN and ClinicalTrials.gov list studies and their results. Crohn's & Colitis UK explains how new medicines are tested before they are licensed.

Sources

Does Crohn's run in families?

It can. The NHS says you may be more likely to get Crohn's if other people in your family have it. Crohn's & Colitis UK says researchers have found more than 200 gene variations that affect the risk, many involved in the immune system. Guts UK says about one in five people with Crohn's has a relative with it, but that genes alone do not decide who gets it.

Sources

How do I take part in Crohn's research?

Ask your IBD team whether your hospital is running any studies. You can also search the NIHR's Be Part of Research website, which lists UK studies currently recruiting people with Crohn's. The IBD BioResource invites people with Crohn's or colitis to join a national panel and be contacted about future studies. Crohn's & Colitis UK also lists ways to help shape research, such as patient and public involvement.

Sources

What is a Cochrane review and why does it matter?

Cochrane reviews are systematic reviews: researchers find every good trial on a question, judge how reliable each one is and combine the results. They also grade how certain the evidence is. For Crohn's, Cochrane has found strong evidence for some treatments, such as vedolizumab, and too little evidence to judge others, such as treatments for fatigue.

Sources

Where to read more

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

Nature Study May 2001 For professionals

One of two papers published together in 2001 that found the first gene firmly linked to Crohn's, NOD2. A change in this gene produces a faulty version of a protein that normally helps the immune system recognise bacteria. It pointed to an abnormal reaction to gut bacteria as part of what causes Crohn's.

Topics About Crohn's disease Research

Jargon explained NOD2 mutation susceptibility gene innate immunity

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Nature Study Nov 2012 For professionals

A huge international genetics study that mapped many gene regions linked to Crohn's and colitis. Many of these are shared with other immune conditions such as ankylosing spondylitis and psoriasis, and with the body's response to bacteria such as those that cause TB. It shows IBD risk is spread across many genes, each adding a small amount.

Topics About Crohn's disease Research

Jargon explained genome-wide association study locus immune-mediated disease

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

Nature Study May 2001 For professionals

The companion to the other 2001 NOD2 paper. It found several variants of the NOD2 gene linked to Crohn's, all in the part of the protein that senses bits of bacteria. It suggested that people with these variants may handle gut bacteria differently, a key step in understanding the causes of Crohn's.

Topics About Crohn's disease Research

Jargon explained NOD2 gene variant genetic susceptibility

IBD BioResource

NIHR BioResource Web page Patients and professionals

A national NIHR project that builds a large panel of people with Crohn's and colitis who agree to share samples and health data and to be invited into future studies. It aims to understand the genetic causes of IBD and why people respond differently to treatment. There is also a children's arm.

Topics Research

Jargon explained bioresource cohort genetic analysis

Clinical trials

NHS Web page Dec 2022 For patients

The NHS explains what a clinical trial is and how to find one. It suggests asking your doctor or a patient organisation, and points to the Be Part of Research website, where you can search UK studies and contact researchers.

Topics Research

Jargon explained clinical trial randomised

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

The Lancet Study Dec 2017 Patients and professionals

CALM compared deciding treatment on symptoms alone with 'tight control', where treatment was stepped up if blood or poo tests (CRP and faecal calprotectin) showed inflammation even when people felt fine. After 48 weeks, 46% in the tight control group had a healed bowel lining compared with 30% in the symptom-only group. It is a cornerstone of the 'treat to target' approach.

Topics Monitoring Biologics and newer medicines Research

Jargon explained tight control faecal calprotectin CRP mucosal healing treat to target

Be Part of Research

NIHR Tool For patients

The NHS research service's search tool for finding health studies to take part in across the UK. Searching for Crohn's disease lists studies currently recruiting, with who can join and where. A good first stop if you want to volunteer for a trial.

Topics Research

Jargon explained clinical trial recruiting

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

The Lancet Study May 2022 Patients and professionals

Two trials testing risankizumab (Skyrizi) drips to bring active Crohn's under control, including in people for whom other biologics had failed. Risankizumab led to more remissions, and more improvement seen on camera tests of the bowel, at 12 weeks than placebo, and was generally well tolerated.

Topics Biologics and newer medicines

Jargon explained induction phase 3 trial endoscopic response

Crohn's disease: What are the causes and risk factors?

NICE CKS Guide May 2024 For professionals

Explains that no single cause of Crohn's has been proven and that it is thought to be an immune-driven condition set off by environmental triggers in people whose genes make them susceptible. It covers family history, smoking (which raises the risk of Crohn's, unlike UC, and is linked to flare-ups and surgery), a past bout of infectious gastroenteritis and other factors that have been studied.

Topics About Crohn's disease Research

Jargon explained immune-mediated gastroenteritis appendicectomy

Dietary interventions for induction and maintenance of remission in inflammatory bowel disease

Cochrane Systematic review Feb 2019 Patients and professionals

Reviewed trials of special diets (such as low-sugar, low-red-meat or exclusion diets) for Crohn's and colitis. The effects were uncertain and no firm conclusions could be drawn. The authors say experts need to agree what the diets should contain and more trials are needed.

Topics Diet and nutrition

Jargon explained dietary intervention randomised controlled trial

Search everything for "genome-wide association study"